Please login to the form below

Not currently logged in

European Research Council readies €2bn in science funding


Aims to reward potential breakthrough discoveries

Samsung deal with Takeda looks beyond biosimilars

Takeda pharma buildingThe duo plan to develop “multiple novel biologic therapies”

Stada's €4.1bn takeover goes through

Stada flagsGerman pharma company finally comes under new ownership

Trump disbands CEO councils after more defections

US president elect Donald TrumpJ&J’s Gorsky resigns following Trump's remark about Charlottesville

Quantum Pharma confirms Clinigen takeover bid

Clinigen has until September 13 to make a formal offer

Type 2 diabetes market set to soar to $64bn by 2026

Rising prevalence, progressive nature and diagnosis of the condition behind the surge

Merck CEO resigns from Trump post in Charlottesville protest

Merck and Co - US headquartersFrazier leaves the Manufacturing Council but J&J’s Gorksy remains for now

Time running out on new Stada takeover bid

Stada flagsOnly 34% of shareholders have backed the deal so far

Ionis must go it alone as GSK ditches polyneuropathy drug

Ionis logoInotersen’s side effects prompts pharma giant to relinquish rights

Ho_Ung_KimStanding out in a crowd

Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

The Pharma Wars Series
The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
What pharma marketers can learn from growth hacking?
Growth hackers instinctively blend technical skills with creative thinking...
Medicines for Europe
The sound of silence puts the squeeze on generics and biosimilars
Medicines for Europe vows to get governments talking to realise potential...